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Maf1-mediated repression of RNA polymerase III
transcription inhibits tRNA degradation via RTD pathway
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ABSTRACT
tRNA precursors, which are transcribed by RNA polymerase III, undergo end-maturation, splicing, and base modifications.
Hypomodified tRNAs, such as tRNAVal(AAC), lacking 7-methylguanosine and 5-methylcytidine modifications, are subject to
degradation by a rapid tRNA decay pathway. Here we searched for genes which, when overexpressed, restored stability of
tRNAVal(AAC) molecules in a modification-deficient trm4Dtrm8D mutant. We identified TEF1 and VAS1, encoding elongation
factor eEF1A and valyl-tRNA synthetase respectively, which likely protect hypomodified tRNAVal(AAC) by direct interactions. We
also identifiedMAF1 whose product is a general negative regulator of RNA polymerase III. Expression of a Maf1-7A mutant that
constitutively repressed RNA polymerase III transcription resulted in increased stability of hypomodified tRNAVal(AAC).
Strikingly, inhibition of tRNA transcription in a Maf1-independent manner, either by point mutation in RNA polymerase III
subunit Rpc128 or decreased expression of Rpc17 subunit, also suppressed the turnover of the hypomodified tRNAVal(AAC).
These results support a model where inhibition of tRNA transcription leads to stabilization of hypomodified tRNAVal(AAC) due to
more efficient protection by tRNA-interacting proteins.
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INTRODUCTION
Regulation of the tRNA transcription machinery and the
post-transcriptional steps that generate functional tRNAs
are of fundamental importance for protein biosynthesis and
cell survival. tRNAs precursors are transcribed by RNA po-
lymerase III (Pol III), a large enzyme consisting of 17 subunits
and requiring several auxiliary factors. tRNA transcription
needs to be controlled in response to nutrient availability and
other environmental circumstances; up-regulation of tRNA
transcription can promote cell proliferation and transfor-
mation as well as tumorigenesis in mice (Marshall et al. 2008).
Mammalian Pol III is controlled by the tumor suppressors
p53 and Rb, and Maf1 protein, which is conserved also in all
eukaryotes (Pluta et al. 2001; White 2004). In yeast, Maf1 is
the only known general negative Pol III regulator which en-
sures coupling of tRNA biosynthesis to cell growth and me-
tabolism (Boguta and Graczyk 2011).
Primary tRNA transcripts are extended at the 59 and 39
termini and may contain introns. Processing of the 59 leader
and trimming of the 39 trailer occur in the nucleus and are
followed by CCA addition at the newly formed 39 termini. In
yeast, the end-processed tRNAs are transported to the cyto-
plasm where introns are removed (for review, see Phizicky
and Hopper 2010). The nuclear export of yeast tRNA is
regulated by environmental conditions in coordination with
Maf1-mediated transcription control, thereby coupling
tRNA synthesis and maturation (Karkusiewicz et al. 2011).
In addition to the processing at the termini and intron
removal, tRNAs undergo nucleotides modification, both in
the nucleus and in the cytoplasm. Modifications in or around
the anticodon loop affect translation and cell growth, while
some body tRNA modifications contribute to its folding and
stability (Chernyakov et al. 2008a). Inappropriately modified
or folded tRNAs can be the target of at least two turnover
mechanisms. Pre-tRNAi
Met lacking m1A is destroyed by the
nuclear surveillance pathway in which the pre-tRNA is first
polyadenylated by the TRAMP complex, and then degraded
from the 39 end by the nuclear exosome (Anderson and
Parker 1998; Kadaba et al. 2004; Kuai et al. 2004; Wyers et al.
2005). Another pathway, called rapid tRNA decay (RTD),
causes partial loss of the hypomodified tRNA in mutant
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lacking specific modifications (Alexandrov et al. 2006;
Kotelawala et al. 2008). One substrate for the RTD
pathway is tRNAVal(AAC), lacking the m
7G46 and m
5C49
modifications. This tRNA is degraded at an elevated
temperature by 59/39 exonucleases, Xrn1 and Rat1
(Chernyakov et al. 2008b). A more recent study has
demonstrated that lack of specific modifications leads to
instability of the tRNA acceptor stem and exposes the 59
end of the tRNA molecule to degradation by Xrn1 nuclease
(Whipple et al. 2011). Instability of acceptor stem causes
tRNA degradation mediated by CCACCA addition at the 39
end (Wilusz et al. 2011).
Here we show that degradation of hypomodified tRNA is
prevented when tRNA transcription is decreased. Inhibi-
tion of Pol III activity in trm4Dtrm8D cells lacking the
m7G46 and m
5C49 modifications in their tRNAs resulted in
lower degradation of tRNAVal(AAC). A similar effect, i.e., sta-
bilization of hypomodified tRNAVal(AAC), could be achieved
in the trm4Dtrm8D mutant by overexpression of genes
encoding translation elongation factor eEF1A or valyl-tRNA
synthetase, two tRNA-interacting proteins. According to our
model, in the context of a globally lower tRNA level,
tRNAVal(AAC) competes more efficiently for tRNA-interacting
proteins which help it achieve proper conformation and/or
protect from nucleases.
RESULTS
Identification of library plasmids that overcome
growth defect related to degradation of tRNAVal(AAC)
Our rationale was that degradation of hypomodified
tRNAVal(AAC) could be limited in vivo by some factors or
as yet undescribed activities affecting the RTD pathway. In
an attempt to identify such putative factors increasing
stability of hypomodified tRNA, we used a genetic strategy
employing the growth phenotype of the trm4Dtrm8D mu-
tant, which is not viable at 37°C due to degradation of the
tRNAVal(AAC) lacking the m7G46 and m
5C49 modifications
(Chernyakov et al. 2008b). We therefore looked for multi-
copy suppressors of the trm4Dtrm8D growth deficiency at an
elevated temperature.
The trm4Dtrm8D strain was transformed with a yeast
genomic library based on the pFL44L multicopy vector
(Stettler et al. 1993). Sixty-five transformants growing at an
elevated temperature (37°C) were selected from z5 3 103
transformed cells. For each of them we determined whether
their temperature resistance required the presence of the
library plasmid. Twenty-nine candidates showed the de-
pendence of the suppression level upon the presence of the
plasmid. Sequencing of the plasmids from those cells iden-
tified 16 inserts containing various tRNAVal(AAC) genes and
13 other inserts. Selection of genomic inserts containing
tRNAVal(AAC) genes was expected in our screen since com-
plementation of the thermosensitive (ts) phenotype of
trm4Dtrm8D mutant by an overdose of the tRNAVal(AAC)
gene had been reported previously (Alexandrov et al. 2006).
All the other plasmids were retransformed into trm4Dtrm8D
and assayed for growth at an elevated temperature. Se-
quencing and subsequent subcloning of the suppressor
plasmids led to the identification of five genes: TEF1, VAS1,
MAF1, RVB2, and POP5. One plasmid contained a 59-
terminal part of the RPC160 gene encoding the largest
subunit of RNA polymerase III.
TEF1 encodes the translation elongation factor eEF1A.
This protein is expressed from two genes in the yeast
genome, TEF1 and TEF2, which contain identical ORFs.
eEF1A is the eukaryotic homolog of Escherichia coli EF-Tu
and binds in a GTP-dependent manner to aminoacyl tRNAs
to deliver them to the ribosome (Mateyak and Kinzy 2010).
We found that not only TEF1 but also TEF2 suppressed the
trm4Dtrm8D defect when overexpressed (TW Turowski,
unpubl.). Thus, the phenotypic effect of the tRNAVal(AAC)
instability could be compensated by an overdosage of eEF1A
for augmenting the eEF1A–tRNA interaction.
Interestingly, eEF1A was not the only tRNA-binding
protein among the identified suppressors (Fig. 1). VAS1 en-
codes valyl-tRNA synthetase, which interacts with tRNAVal
directly. This suggested that the temperature resistance of
trm4Dtrm8D brought about by high level of VAS1 expression
could likewise be due to stabilization of the hypomodified
tRNAVal(AAC) by the interacting protein. Such an interaction
could help the tRNAVal(AAC) achieve a correct conformation
despite the lack of proper modifications or could simply
mechanistically protect it from the degradation machinery.
To address specificity of RTD suppression by tRNA-
interacting proteins, we introduced TEF1 and VAS1 plas-
mids to tan1Dtrm44Dmutant. The lack of Tan1 and Trm44
results in growth defect at 37°C due to degradation of
tRNASer(CGA) and tRNASer(UGA) missing Um44 and ac
4C12
modifications (Kotelawala et al. 2008). The temperature-
sensitive phenotype of tan1Dtrm44D was suppressed by
TEF1 but not by VAS1 overdose (Supplemental Fig. S1).
We thus confirmed that VAS1 suppresses RTD-related
phenotype of trm4Dtrm8D by specifically affecting the
tRNAVal(AAC) levels.
FIGURE 1. Multicopy suppressors of trm4Dtrm8D defect encoding
known tRNA-interacting proteins. trm4Dtrm8D cells were trans-
formed with multicopy plasmid pFL44L carrying VAS1 or TEF1.
tRNAVal(AAC) gene as a positive control and empty plasmid as
a negative control. Transformants were grown overnight at 30°C in
SD-ura liquid media, diluted to OD600 = 1.0 and serially 10-fold
diluted, spotted on YPD plates, and incubated at 30°C or 37°C for 2 d.
Turowski et al.
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Next we examined the effects of TEF1 or VAS1 overdose
on the stability of the hypomodified tRNAVal(AAC). Using
Northern blotting we monitored the degradation of
tRNAVal(AAC) following a shift of trm4Dtrm8D cells to an
elevated temperature (Fig. 2). The level of Pol I-synthesized
5.8S rRNA served as an internal control. As published
before (Chernyakov et al. 2008b), tRNAVal(AAC) lacking the
m7G46 and m
5C49 modifications is rapidly degraded at 37°C
(Fig. 2). Importantly, overexpression of TEF1 or VAS1
suppressed the tRNAVal(AAC) loss. Thus, an overdose of
eEF1A or valyl-tRNA synthetase suppresses phenotype of
trm4Dtrm8D mutant by preventing degradation of hypo-
modified tRNAVal(AAC) at an elevated temperature.
Whether the hypomodified tRNAVal(AAC) also interacts
with proteins encoded by the other suppressors of the
trm4Dtrm8D phenotype is only speculative. POP5 encodes
a subunit of RNAse P which cleaves tRNA precursors to
generate mature 59 ends. Rvb2, a component of Rvb1/Rvb2
reptin complex, is essential in the assembly of several mac-
romolecular complexes in transcription regulation and
chromatin remodeling (Jha and Dutta 2009). The suppres-
sion by POP5 and RVB2 may be therefore indirect. Here,
we have focused on two of the suppressors identified, TEF1
and VAS1, as their encoded proteins were known tRNA
interactors. The remaining suppressors are of interest as
well and will be studied later.
Hypomodified tRNAVal(AAC) is stabilized
by Maf1 overproduction
Identification of the gene encoding Maf1 as a high copy
suppressor of the trm4Dtrm8D phenotype was surprising
(Fig. 3A). Maf1 is a global negative regulator of Pol III
transcription which, in an active state, decreases pre-tRNA
synthesis (Pluta et al. 2001; Upadhya et al. 2002). Simple
overexpression of MAF1 gene has little effect on the Pol III
transcription (Desai et al. 2005) since activation of Maf1
requires its dephosphorylation (Oficjalska-Pham et al. 2006).
By employing Northern blotting we confirmed that the
steady state level of hypomodified tRNAVal(AAC) was actually
not changed by increased expression of Maf1-encoding gene
(Fig. 3B). The molecular mechanism of trm4Dtrm8D sup-
pression by overexpression of MAF1 is therefore not related
to a compensatory synthesis of tRNAVal(AAC). In contrast, an
overdose of the tRNAVal(AAC) gene more than doubled the
steady state level of this tRNA at the permissive temperature
(Fig. 3C).
To evaluate the effect of Maf1 on the RTD pathway we
monitored the degradation of tRNAVal(AAC) following a shift
of trm4Dtrm8D cells to an elevated temperature (Fig. 3B).
Importantly, MAF1 overexpression partially suppressed the
tRNAVal(AAC) loss. Quantification of the Northern blots re-
vealed that after 2 h at the elevated temperature tRNAVal(AAC)
is present at only 20% of the level before temperature shift
in the trm4Dtrm8D strain transformed with a control plas-
mid. In contrast, in the trm4Dtrm8D strain transformed with
a Maf1-encoding multicopy plasmid, the tRNAVal(AAC) level
was 40% of the level before the temperature shift (twofold
more than without overexpression of Maf1). An overnight
incubation at 37°C results in a complete loss of tRNAVal(AAC)
and death of trm4Dtrm8D cells, both suppressed by MAF1
overdose (Fig. 3A; Supplemental Fig. S2).
In summary, overproduction of Maf1, a Pol III repressor,
affords limited stabilization of hypomodified tRNAVal(AAC).
Maf1-7A mutant, a constitutively active Pol III
repressor, stabilizes hypomodified tRNAVal(AAC)
Identification of Maf1-encoding gene in the screen for pro-
teins involved in stabilization of hypomodified tRNAVal(AAC)
raised the question of the mode of action of Maf1. Maf1
shuttles between the nucleus and the cytoplasm (Towpik
et al. 2008). Its function in the cytoplasm is unknown, but
one possibility is that cytoplasmic Maf1 could be directly
involved in tRNA stabilization. However, our attempts to
identify a direct Maf1–tRNAVal(AAC) interaction failed (I
Karkusiewicz and TW Turowski, unpubl.). We therefore
explored the possibility of an indirect role of Maf1 in tRNA
stabilization deriving from the known negative effect of Maf1
FIGURE 2. Multicopy suppressors of trm4Dtrm8D stabilize hypo-
modified tRNAVal(AAC). trm4Dtrm8D cells transformed with multi-
copy plasmid carrying either VAS1 [2m VAS1] or TEF1 [2m TEF1] or
empty plasmid [2m] were grown at 23°C and shifted to 37°C for 2 h.
RNA was isolated and analyzed by Northern hybridization with
tRNAVal(AAC) probe and 5.8S rRNA probe (loading control). For
quantification of tRNAVal(AAC) levels were normalized to 5.8S rRNA.
Bars represent magnitude of tRNAVal(AAC) change calculated relative
to expression in trm4Dtrm8D cells bearing empty plasmid at 0 time
point. Standard deviation (SD) was calculated on the basis of three
independent experiments. P-values—P < 0.01 for the probe indicated
with a single asterisk (*) and P < 0.005 for the probe indicated with
two asterisks (**)—were calculated relative to control strain trans-
formed with empty plasmid [2m] at 120 time point.
tRNA transcription and tRNA decay are coupled
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on tRNA transcription. We expected that an enhancement of
the Maf1-mediated repression by its dephosphorylation
would promote stabilization of hypomodified tRNAVal(AAC).
We therefore used the constitutively dephosphorylated Maf1-
7A mutant (Huber et al. 2009). Cells expressing Maf1-7A had
reduced basal tRNA levels due to an increased capacity of
Maf1-7A to bind and inhibit Pol III
(Huber et al. 2009). First we verified the
functionality of Maf1-7A encoded by
a centromeric plasmid by genetic com-
plementation (Supplemental Fig. S3A).
Then the dephosporylated state of Maf1-
7A was verified under our experimental
conditions. Crude extracts were pre-
pared from trm4Dtrm8Dmaf1D cells
expressing Maf1-7A from a centromeric
plasmid. Differentially phosphorylated
forms of Maf1 were resolved by SDS-
PAGE and identified by immunoblot-
ting at various times after culture trans-
fer to 37°C. As reported previously,
Maf1-7A is constitutively dephosphory-
lated whereas wild-type Maf1 remains
phosphorylated upon this transition
(Supplemental Fig. S3B). Moreover, total
tRNA is reduced in Maf1-7A mutant
to the same extend as previously identi-
fied using other experimental conditions
(Supplemental Fig. S3C; Huber et al.
2009).
Having established the expected
properties of Maf1-7A we studied its
effect on the growth of trm4Dtrm8D
mutant at elevated temperature. No-
tably, expression of Maf1-7A in both
trm4Dtrm8Dmaf1D and trm4Dtrm8D
cells resulted in suppression of their
temperature-sensitive phenotype (Fig.
4A). Additionally plasmid encoding
Maf1-7A suppressed the temperature-
sensitive phenotype of tan1Dtrm44D
mutant related to increased turnover
of tRNASer(CGA) and tRNASer(UGA) (Sup-
plemental Fig. S4).
To further characterize effect of
Maf1-7A, we investigated whether sup-
pression was linked to stabilization of
hypomodified tRNA. By Northern blot-
ting we compared levels of tRNAVal(AAC)
in trm4Dtrm8Dmaf1D cells harboring
control vector and centromeric plasmids
encoding wild-type Maf1 or Maf1-7A
(Fig. 4B). Before the temperature shift
level of tRNAVal(AAC) is slightly higher
in control cells lacking Maf1. Following
2-h incubation of cells at 37°C, z60% of tRNAVal(AAC)
was, however, degraded and the extent of degradation was
similar in the presence of wild-type Maf1 expressed at
basal level. Indeed tRNAVal(AAC) was significantly more
stable in the presence of Maf1-7A since only 40% was
degraded.
FIGURE 3. Overproduction of Maf1 suppresses thermosensitive phenotype and stabilizes
hypomodified tRNAVal(AAC) in trm4Dtrm8D cells. (A) trm4Dtrm8D cells were transformed with
multicopy pFL44L plasmid with MAF1 [2m MAF1] or empty plasmid [2m]. Transformants
were grown overnight at 30°C in SD-ura liquid media, diluted to OD600 = 1.0 and serially
10-fold diluted, spotted on YPD plates, and incubated at 30°C or 37°C for 2 d. (B) trm4Dtrm8D
cells harboring control empty plasmid [2m] or plasmid with MAF1 [2m MAF1] were grown in
SC-ura medium at 30°C to OD = 1.0, shifted to 37°C, and incubated for the indicated time.
RNA was isolated and analyzed by Northern hybridization with tRNAVal(AAC) probe and 5.8S
rRNA probe (loading control). For quantification of tRNAVal(AAC) levels were normalized to 5.8S
rRNA. Bars represent magnitude of tRNAVal(AAC) change calculated relative to expression in
trm4Dtrm8D cells bearing empty plasmid at 0 time point. SD was calculated on the basis of three
independent experiments. P-value < 0.01 for the indicated probe (*) was calculated relative to
control strain transformed with empty plasmid [2m] at 120 time point. (C) trm4Dtrm8D
transformants with multicopy plasmid carrying gene coding tRNAVal(AAC) [2m tRNAVal(AAC)] or
empty plasmid [2m] were grown at 23°C and shifted to 37°C for 2 h, RNA was isolated and
analyzed by Northern hybridization as in B. Relative levels of tRNAVal(AAC) were quantified (note
that the scale is different than in B).
Turowski et al.
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These results show that the variant of Maf1 repressor,
previously described in the literature as dephosphorylated
and interacting with Pol III even under unstressed condi-
tions (Huber et al. 2009), efficiently promotes stabilization
of hypomodified tRNAVal(AAC).
Decreased Pol III transcription stabilizes
hypomodified tRNAVal(AAC)
Next we asked whether repression of Pol III transcription
by non-Maf1-mediated mechanisms would also stabilize
tRNAVal(AAC) in trm4Dtrm8D cells. First we employed
rpc128-1007 mutation in the Rpc128 Pol III subunit, which
halves the overall tRNA transcription (Ciesla et al. 2007).
The cold-sensitive (cs) rpc128-1007 mutant was crossed
with the trm4Dtrm8D strain and the meiotic progeny was
analyzed (see Materials and Methods). The observed
phenotypic segregation indicated that rpc128-1007 sup-
pressed the ts growth defect of trm4Dtrm8D (Fig. 5A). In
accordance with the suppressed growth defect, Northern
blotting revealed that the hypomodified tRNAVal(AAC) was
more stable in the presence of rpc128-1007 mutation,
FIGURE 4. Maf1-7A mutant suppresses thermosensitive phenotype and stabilizes tRNAVal(AAC) in trm4Dtrm8D cells. trm4Dtrm8Dmaf1D strain,
generated as described in Materials and Methods, was transformed with empty plasmid pRS415 [CEN], pAH095 encoding wild-type Maf1 [CEN
MAF1], or pAH247 encoding Maf1-7A mutant [CEN MAF1-7A]. (A) Transformants were grown overnight at 30°C in SD-ura liquid media,
cultures were diluted to OD600 = 1.0 and serially 10-fold diluted, spotted on YPD plate, and incubated at 30°C or 37°C for 2 d. (B) Cells were
grown in SC-Leu at 23°C, transferred to 37°C, and harvested as indicated. RNA was isolated and analyzed by Northern hybridization with
tRNAVal(AAC) probe and 5.8S rRNA probe (loading control). For quantification of tRNAVal(AAC) levels were normalized to 5.8S rRNA. Bars
represent magnitude of tRNAVal(AAC) change calculated relative to expression in trm4Dtrm8D cells bearing empty plasmid at 0 time point. SD was
calculated on the basis of three independent experiments. P-value < 0.005 for the indicated probe (**) was calculated relative to control strain
transformed with empty plasmid [CEN] at 120 time point.
tRNA transcription and tRNA decay are coupled
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although de novo transcription is decreased, resulting in
reduced level of total tRNA (Fig. 5B; Supplemental Fig.
S5A). Quantification of the blots employing an intron
probe showed that the rpc128-1007 mutation decreased
de novo synthesis of pre-tRNALeu in the trm4Dtrm8D strain
by 40%. The steady state level of tRNAVal(AAC) at the
permissive temperature was also significantly lower in triple
trm4Dtrm8D rpc128-1007 mutant (z75% of that in double
trm4Dtrm8D mutant). However, following the tempera-
ture shift, tRNAVal(AAC) level was reduced only by 20% in
trm4Dtrm8D rpc128-1007 in contrast to the reduction ex-
ceeding 70% in trm4Dtrm8D.
As a yet another approach we decreased Pol III tran-
scription by partial inactivation of its Rpc17 subunit through
expression of RPC17 gene cloned under the regulated tetO7
promoter. Addition of doxycycline to the growth medium
decreased the level of Rpc17 protein and reduced tRNA
transcription whereas in the absence of the antibiotic Pol III
was unaffected (Ferri et al. 2000). To monitor the effect of
Rpc17 level on the stability of hypomodified tRNAVal(AAC) we
created a trm4Dtrm8D strain expressing RPC17 from the
tetO7 promoter. In the presence of doxycycline, Northern
blot with an intron probe of pre-tRNALeu indicated that
repression of Rpc17 expression impaired Pol III transcription
and reduced tRNA levels (Fig. 5D; Supplemental Fig. S5B).
Northern blotting revealed also that tRNAVal(AAC) was mostly
degraded when the Rpc17 level was high in the absence of
doxycycline but was more than twice stable when Rpc17
expression and Pol III activity were decreased in the presence
of doxycycline. In keeping with the tRNAVal(AAC) stabilization
the ts phenotype of the trm4Dtrm8D strain expressing RPC17
from the tetO7 promoter was suppressed in the presence of
doxycycline (Fig. 5C).
Altogether these results clearly indicate an inverse relation-
ship between the stability of hypomodified tRNAVal(AAC) and
the activity of Pol III-directed transcription.
DISCUSSION
Our interest in the global regulation of tRNA levels, in-
volving transcription, maturation and decay, led us to
screen for gene products that control the stability of
hypomodified tRNAVal(AAC). We anticipated that we would
uncover genes compensating for the lowered steady state
level and specific modifications missing in tRNAVal(AAC), in
addition to those involved in indirect mechanisms affecting
tRNA decay. As anticipated, most of the insert cloned
contained one of the thirteen copies of genes encoding
tRNAVal(AAC). Surprisingly, no genes encoding tRNA-
methyltransferases were uncovered. Actually, two other
categories of gene products were identified: those affect-
ing global tRNA transcription—Maf1 and truncated Pol III
subunit Rpc160—and those directly interacting with
tRNAVal(AAC)—elongation factor eEF1A and valyl-tRNA
synthetase.
In yeast, Maf1 is the only known general and global
negative regulator of Pol III which mediates several signal-
ing pathways (Upadhya et al. 2002). Maf1 inhibits tRNA
transcription via a mechanism that depends on the de-
phosphorylation and nuclear accumulation of Maf1 fol-
lowed by its physical association with Pol III at tRNA genes.
Conversely, Maf1 phosphorylation occurs in favorable
growth conditions and is linked with its cytoplasmic local-
ization (Moir et al. 2006; Oficjalska-Pham et al. 2006;
Roberts et al. 2006).
We have shown recently that Maf1 indirectly affects
maturation of tRNA precursors (Karkusiewicz et al. 2011).
End-matured intron-containing pre-tRNAs accumulate in
cells lacking Maf1 due to saturation of processing machin-
ery by the increased amounts of primary transcripts. Here
we have shown that the phenotype of the trm4Dtrm8D
mutant can be suppressed by overexpression of the Maf1-
encoding gene or, more efficiently, expression of the de-
phosphorylated Maf1-7A mutant that constitutively binds
the Pol III complex and reduce tRNA transcription (Huber
et al. 2009). The suppression by overexpressed Maf1-
encoding gene is accompanied by a twofold stabilization
of hypomodified tRNAVal(AAC), while Maf1-7A mutant
with reduced basal tRNA levels due to an increased capacity
of Maf1-7A to bind and inhibit Pol III gives even stronger
effect. Selection of a plasmid containing a 59-terminal part
of the RPC160 gene as an autonomous suppressor of the
trm4Dtrm8D defect was anticipated and validates the Maf1-
mediated suppression. Interaction of Maf1 with the Rpc160
subunit of Pol III has been documented both genetically and
by structural analysis of Pol III with Maf1 (Pluta et al. 2001;
Vannini et al. 2010). Overexpression of a 59-terminal frag-
ment as well as point mutations in the RPC160 gene were
identified previously as suppressors of the maf1D growth
phenotype. That suppression was accompanied by reduction
of tRNA levels in maf1D cells (Boguta et al. 1997; Pluta et al.
2001). In view of those earlier data, the similar suppressor
actions of Maf1 and the N-terminal part of Rpc160 on the
trm4Dtrm8D growth defect were expected.
The increased stability of hypomodified tRNAVal(AAC)
caused by Maf1 activation raised the idea that the observed
stabilization could be related to Maf1-mediated repression
of Pol III transcription. Initially this hint seemed to be
inconsistent with the previous observation that cells treated
with the thiolutin, Pol III inhibitor, carry out the tRNA
degradation at the same rate (Chernyakov et al. 2008b).
However thiolutin inhibits all RNA polymerases (Tipper
1973), exerting side effects which in turn possibly influence
tRNA stabilization. Moreover, cells treated with thiolutin
for a short time have stopped pre-tRNA transcription, but
levels of mature tRNAs are not affected (Chernyakov et al.
2008b). In favor of coupling tRNA transcription to tRNA
decay we found that tRNAVal(AAC) in trm4Dtrm8D cells was
stabilized upon Pol III inhibition, either in a Maf1-dependent
manner or when directly down-regulating general tRNA
Turowski et al.
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transcription by two means: by introduction of the rpc128-
1007 mutation in the Pol III subunit Rpc128 or by de-
creasing expression of another subunit, Rpc17. Regardless
of the approach used, the reduced Pol III activity and, in
consequence, lower levels of total tRNA
brought about a significant stabilization
of the hypomodified tRNAVal(AAC).
Proposed mechanism that could ac-
count for the effect of Pol III inhibition
on stabilization of tRNAVal(AAC) is that,
in the context of a globally lower ma-
ture tRNA level, tRNAVal(AAC) could
more efficiently compete for tRNA-
interacting proteins helping it achieve
proper conformation and/or protecting
it from nucleases. We favor the latter
interpretation because at least two of the
multicopy suppressors of the trm4Dtrm8D
mutant selected in our screen encoded
tRNA-interacting proteins, eEF1A and
valyl-tRNA synthetase, and overexpres-
sion of either of those genes also stabi-
lized tRNAVal(AAC).
Taken together, our studies propose
two alternative ways by which RTD
degradation could be limited: a decrease
in tRNA synthesis and an increase in the
levels of specific tRNA-interacting pro-
teins protecting tRNA from degrada-
tion. According to our model (Fig. 6),
mature tRNAs compete with each other
for interacting proteins and thus the
availability of some such proteins be-
comes limiting. Due to the missing
m7G46 and m
5C49 modifications, the
tertiary structure of the acceptor and T
stems in tRNAVal(AAC) is imperfect or less
stable (reference in Whipple et al. 2011)
and, therefore, the interaction of this
tRNA with proteins is compromised. It
would be a poorer competitor for valyl-
tRNA synthetase or eEF1A than other
tRNAs. A globally decreased tRNA syn-
thesis would relief that competition by
decreasing the overall tRNA:protein ra-
tio, thereby allowing even the imperfect,
hypomodified tRNAVal(AAC) to find its
match(es). Overexpression of limiting
protein partner(s) would reduce the
same effect and we suggest that this ex-
plains the suppression by valyl-tRNA
synthetase and eEF1A. On the other
hand, the altered structure of hypomo-
dified tRNAVal(AAC) makes it more sus-
ceptible to degradation by 59/39 exo-
nucleases. This instability may also lead to isomerization of
the acceptor stem, which is then subject to double CCA
addition and can also be polyadenylated at the 39 end like
observed for hypomodified tRNASer(CGA) (Wilusz et al. 2011).
FIGURE 5. Partial inactivation of Pol III subunit results in suppression of trm4Dtrm8D ts
phenotype and tRNAVal(AAC) stabilization. (A) Cold-sensitive rpc128-1007 mutation in Pol III
subunit Rpc128 was introduced to trm4Dtrm8D strain by genetic cross, resulting in triple
trm4Dtrm8Drpc128-1007 mutant. Serial 10-fold dilutions of BY4741 (wt), rpc128-1007,
trm4Dtrm8D, and trm4Dtrm8Drpc128-1007 cells were spotted on YPD plates and incubated
at indicated temperatures. (B) Cells were grown in YPD to OD600 = 1.0 at 30°C, transferred to
37°C, and harvested as indicated. RNA was isolated and examined by Northern hybridization
with probe specific for tRNAVal(AAC). Plots represent levels of tRNAVal(AAC) normalized to
loading control (5.8S rRNA). The magnitude of change was calculated relative to expression in
trm4Dtrm8D strain at 0 time point. SD was calculated on the basis of three independent
experiments. P-values—P < 0.01 for the probe indicated with a single asterisk (*) and P <
0.005 for the probe indicated with two asterisks (**)—were calculated relative to control strain
at each time point. (C) Gene encoding Rpc17 subunit of Pol III was cloned in trm4Dtrm8D
strain under the regulated tetO7 promoter to allow down-regulation of RPC17 expression by
doxycycline. Serial 10-fold dilutions of trm4Dtrm8D tetO7TRPC17 and control cells were
spotted to YPD plate containing 5 mg/mL of doxycycline and incubated for 2 d at indicated
temperatures. Phenotypic suppression of the ts phenotype trm4Dtrm8D was most efficient at
36°C. (D) trm4Dtrm8D tetO7TRPC17 cells were grown in YPD with or without 2 mg/mL of
doxycycline to OD600 = 1.0 at 23°C, transferred to 37°C, and harvested as indicated. RNA was
isolated and examined by Northern hybridization with probe specific for tRNAVal(AAC). Plots
represent levels of RNAVal(AAC) normalized to loading control (5.8S rRNA). The magnitude of
change was calculated relative to expression in culture without doxycycline at zero (0) time
point. SD was calculated on the basis of three independent experiments. P-values—P < 0.005
for the probes indicated with two asterisks (**)—were calculated relative to control strain at
each time point.
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How does eEF1A prevent degradation of the unstable,
hypomodified tRNAVal(AAC) by RTD degradation? eEF1A is
a homolog of E. coli EF-Tu, which interacts with the accep-
tor stem of aminoacyl-tRNA (Stark et al. 2002; Valle et al.
2002). Here we assume that eEF1A and 59/39 exonucle-
ases interact with the partially unstable tRNAVal(AAC) in a
competitive manner. Fine-tuning of the competitive in-
teraction between decay enzymes and other tRNA-binding
proteins could be significant in tRNA evolution, both at the
level of nucleotide sequence and nucleotide modifications.
The binding of EF-Tu with aa-tRNA depends on the se-
quence and structure of T stem (Schrader et al. 2011). An
aa-tRNA has to bind to EF-Tu with sufficient strength to
form a complex with the ribosome, but weakly enough to
allow the aa-tRNA to be released during decoding. In-
troduction of a T-stem sequence from tightly binding
tRNA to a weakly binding one results in very low rate of
peptide bond formation. Assuming that improper binding
of tRNA with eEF1A increases the accessibility of this tRNA
to 59/39 exonucleases, the RTD-medi-
ated degradation could provide a posi-
tive tRNA selection in evolution.
MATERIALS AND METHODS
Strains, plasmids, and media
Yeast strains BY4741 (a his3D1 leu2D0
met15D0 ura3D0), BY4742 (a his3D1
leu2D0 lys2D0 ura3D0), and isogenic trm4D
and trm8D were purchased from Euroscarf.
The trm4Dtrm8D haploid and homozygous
diploid mutants, DTT1A (a his3D1 leu2D0
lys2D0 met15D0 ura3D0 trm4DTkanMX4
trm8DTkanMX4) and DTT 2n (a/a his3D1/
his3D1 leu2D0/leu2D0 lysD0/LYS2 metD15/
metD15 ura3D0/ura3D0 trm4DTkanMX4/
trm4DTkanMX4 trm8DTkanMX4/trm8DT
kanMX4), respectively, were obtained by
genetic crosses. Single copy of endogenous
MAF1 gene in DTT 2n was disrupted by




resulting in 2:2 segregation of viable
MAF1 Ura spores. Ura+ spores containing
maf1TURA3 allele germinated only at 18°C
and showed a 12-h lag in growth at 30°C.
This growth defect was complemented with
MAF1 gene supplied from plasmid. To
generate trm4Dtrm8D cells expressing Maf1-
7A, trm4Dtrm8Dmaf1DTURA3 spore clone
was transformed with single copy plasmid
pAH247 (pRS415TMAF1-7A [S90A, S101A,
S177A, s178A, S179A, S209A, S210A]; Huber
et al. 2009).
BY derivatives trm44D and tan1D were purchased from Euroscarf.
tan1Dtrm44D mutant was generated by genetic cross.
Triple rpc128-1007 trm4Dtrm8D mutant was isolated from among
meiotic progeny of a cross rpc128-1007 (cs) with trm4Dtrm8D (ts).
Thirteen tetrads were analyzed for kanamycin resistance and growth
at 37°C and 18°C. The cs phenotype indicating rpc128-1007
segregated 2:2. Double trm4Dtrm8D deletions were identified
among kanamycin resistance spore clones by PCR analysis of
genomic DNA. All spore clones identified as trm4Dtrm8Drpc128-
1007 grew at 37°C.
The pCM189[RPC17] plasmid encoding repressible Rpc17 Pol
III subunit was created in E. coli strain MH1 from pCMc17 (Ferri
et al. 2000) using pCM189 (Euroscarf) as backbone. Single copy of
endogenous RPC17 gene was replaced in trm4D trm8D homozy-
gous diploid yeast strain by HIS3 cassette and the obtained
strain (relevant genotype RPC17/rpc17DTHIS3 trm4DTkanMX4/
trm4DTkanMX4 trm8DTkanMX4/trm8DTkanMX4) was trans-
formed with pCM189[RPC17] plasmid and sporulated. The
growth of spore clones containing rpc17DTHIS3 allele and
pCM189[RPC17] plasmid was sensitive to doxycycline (2 mg/mL
in solid YPD) but resistant to elevated temperature.
FIGURE 6. Model for eEF1A-mediated protection of tRNAVal(AAC) from RTD degradation.
Mature, hypomodified tRNAVal(AAC) pool is aminoacylated by valyl-tRNA synthetase, bound
by eEF1A, and delivered to ribosomes. A shift to restrictive conditions results in degradation of
hypomodified tRNAVal(AAC) by RTD pathway. It is unknown whether hypomodified tRNA can
be efficiently charged and if it could be degraded prior to aminoacylation. Nevertheless,
elevated population of eEF1A molecules favors their binding to tRNAVal(AAC) and prevents
tRNAVal(AAC) interacting with nucleases. Increased availability of tRNA-free eEF1A molecules
may be achieved by increased expression of TEF1 gene or decreased global tRNA synthesis by
Pol III inhibition.
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Yeast YPD or YPGly complete media contained 1% yeast
extract, 2% peptone, and 2% glucose or 2% glycerol, respectively.
The minimal media, SC-ura or SC-leu, containing 0.67% yeast
nitrogen base and 2% glucose or glycerol were supplemented with
all necessary requirements without uracil or leucine, respectively.
Solid media contained 2% agar. All reagents were from Difco.
Cloning of trm4Dtrm8D defect suppressors
Suppressors of trm4Dtrm8D were cloned by complementation of
the ts growth phenotype on YPD medium. trm4Dtrm8D strain was
transformed with yeast genebank on multicopy pFL44L vector
provided by F. Lacroute (Stettler et al. 1993) and plated on SC-
ura. About 5000 URA+ transformants were replicated onto YPD
medium and incubated at 37°C for 7 d, with growth monitored
every day. POP5 was subcloned from p47 plasmid containing
genomic fragment of chromosome I (coordinates 80144–84902)
by ligation of NarI-NarI fragment to pFL44L empty vector.
Northern analysis
Cells were grown according to Alexandrov et al. (2006) with
modification. One-hundred milliliters of culture grown at 23°C to
OD600 = 1.0 was rapidly mixed with 400 mL of media preheated to
42°C. The cultures were further incubated at 37°C and harvested
at time points indicated by centrifugation in a rotor preheated to
37°C. For cold-sensitive strains with rpc128-1007 mutation or
overexpressed MAF1 100 mL of culture grown at 30°C to OD600 =
1.0 was rapidly mixed with 400 mL of media preheated to 40°C.
Repression of RPC17 gene in liquid cultures was done by adding
doxycycline (Sigma) to 2 mg/mL final concentration and further
incubation for z24 h to OD600 = 1.0. RNA was extracted and
hybridized as described previously (Graczyk et al. 2011). The
following probes were employed: tRNAVal(AAC): TGGTGATTTCGCC
CAGGA; tRNALeu(CAA) intron: TATTCCCACAGTTTGCGGTCA;
5.8S rRNA: GCGTTGTTCATCGATGC. After hybridization
blots were washed 3 3 10 min with 13 SSC, 1% SDS and
2 3 10 min with 0.53 SSC, 0.1% SDS at 37°C, exposed to a
phosphoimager screen (Fujifilm). RNA was quantified using
FLA-7000 PhosphoImager (Fujifilm). Band intensities were
quantified using Multi Gauge V3.0 Software. The statistical
significance was computed using a t-test as implemented in the
OpenOffice.org environment.
Western analysis
Cells were broken and proteins isolated as described previously
(Towpik et al. 2008). Protein extracts were separated on 10%
(acrylamide:bisacrylamide 33.5:0.3) SDS-PAGE and hybridized
with Maf1-specific antibody as described previously (Gajda et al.
2010).
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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